Clearview Cancer Institute physicians have conducted clinical research for over 20 years in Phases I-IV clinical research trials, bringing the latest treatments to their patients.
According to the NCCN guidelines, the best option of an oncology patient is participation in a clinical trial. Clearview Cancer Institute has been involved in clinical research for over 20 years and has developed usher drugs such as Avastin, Rituxan, Gleevec, Gemzar and Xgeva (to name a few) to market for use in standard of care therapy in oncology.
The commitment to research remains strong and Clearview Cancer Institute focuses on clinical research for novel agents and diagnostics aimed at improving the lives and care of oncology patients. CCI works with pharmaceutical, biotechnology molecular diagnostic and various research organizations, including Sarah Cannon Research Institute and the NCI’s Clinical Trial Support Unit (CTSU) to provide the latest treatments available in research that match our patient populations and for diseases with limited treatment options. Clinical trials available at CCI are found here. Trials available across the USA and beyond are searchable at the following website that is maintained by NIH - http://clinicaltrials.gov
Russel Hill Cancer Foundation 3601 CCI Drive Huntsville, AL 35805 256-503-8241